Tema Etfs LLC Sells 18,331 Shares of Schrodinger, Inc. $SDGR

Key Points

• Tema Etfs LLC reduced its holdings in Schrodinger, Inc. by 52.7%, selling 18,331 shares and leaving it with 16,457 shares valued at approximately $325,000.
• Schrodinger reported a quarterly loss of ($0.59) EPS, which was better than analysts' expectation of ($0.83), alongside a revenue increase of 15.7% year-over-year.
• Several analysts provided mixed ratings on Schrodinger, with Barclays setting a price objective of $25.00 and Citigroup downgrading its rating to neutral with a $20.00 target price.

Tema Etfs LLC cut its holdings in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 52.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,457 shares of the company's stock after selling 18,331 shares during the period. Tema Etfs LLC's holdings in Schrodinger were worth $325,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Two Sigma Advisers LP bought a new position in shares of Schrodinger in the fourth quarter valued at approximately $473,000. Allspring Global Investments Holdings LLC lifted its stake in Schrodinger by 30.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 174,371 shares of the company's stock valued at $3,442,000 after purchasing an additional 40,568 shares during the last quarter. GAMMA Investing LLC lifted its stake in Schrodinger by 118.5% in the first quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after purchasing an additional 3,313 shares during the last quarter. BNP Paribas Financial Markets purchased a new position in Schrodinger in the fourth quarter valued at approximately $330,000. Finally, Two Sigma Investments LP purchased a new position in Schrodinger in the fourth quarter valued at approximately $1,939,000. 79.05% of the stock is owned by institutional investors.

Schrodinger Price Performance

Shares of SDGR stock opened at $19.76 on Friday. The company's fifty day simple moving average is $20.55 and its two-hundred day simple moving average is $22.00. Schrodinger, Inc. has a 1 year low of $16.60 and a 1 year high of $28.47. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of -7.97 and a beta of 1.67.

Schrodinger (NASDAQ:SDGR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.24. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. The business had revenue of $54.76 million for the quarter, compared to analysts' expectations of $52.03 million. During the same quarter in the previous year, the firm posted ($0.66) EPS. The business's revenue for the quarter was up 15.7% compared to the same quarter last year. Equities research analysts anticipate that Schrodinger, Inc. will post -2.37 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Barclays assumed coverage on Schrodinger in a research note on Thursday, August 14th. They issued an "overweight" rating and a $25.00 price objective on the stock. KeyCorp dropped their price objective on Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a research note on Monday, July 14th. Morgan Stanley dropped their price objective on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Monday, August 18th. Finally, Citigroup downgraded Schrodinger from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $35.00 to $20.00 in a research note on Friday, August 15th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $27.83.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.